Key result
Epinephrine infusion reversed verapamil's electrophysiologic effects and facilitated PSVT induction in 46.7% (7 of 15) of patients whose arrhythmias were initially suppressed by verapamil.
Why the study?
It was unclear whether epinephrine infusion reverses verapamil's electrophysiologic effects and predicts stress-related recurrences of PSVT during long-term verapamil treatment.
Does epinephrine infusion reverse the electrophysiologic effects of verapamil and predict stress-related recurrences of PSVT in patients on long-term verapamil?
Does epinephrine infusion reverse the electrophysiologic effects of verapamil and predict stress-related recurrences of PSVT in patients on long-term verapamil?
Epinephrine infusion reverses the electrophysiologic effects of verapamil and can predict stress-related recurrences of PSVT during long-term verapamil therapy.
Answers are grounded in this paper and cite their sources.
May identify verapamil-treated PSVT patients at risk for stress recurrences; hypothesis-generating, should not yet change practice.
The purpose of our study was to determine whether an infusion of epinephrine reverses the electrophysiologic effects of verapamil and whether reversal of verapamil's effects on the induction of paroxysmal supraventricular tachycardia (PSVT) by epinephrine during electropharmacologic testing is predictive of stress-related recurrences of PSVT during long-term treatment with verapamil. The infusion rates of epinephrine used in this study were 25 and 50 ng/kg/min, which previously have been demonstrated to result in plasma epinephrine concentrations in the range that occurs during a variety of stresses in humans. The subjects of this study were 17 patients with recurrent PSVT who underwent an electrophysiologic study in the control state and after at least 2 days of treatment with 240-480 mg/day verapamil. After assessing the response to verapamil, epinephrine was infused and testing was repeated. Verapamil significantly slowed atrioventricular conduction and prolonged refractoriness in the atrium and atrioventricular node. The effects of the two infusion rates of epinephrine were generally similar in magnitude and, therefore, the results were pooled. Epinephrine partially or completely reversed all of verapamil's electrophysiologic effects. Verapamil suppressed the induction of sustained PSVT in 15 patients. Epinephrine facilitated the induction of PSVT in seven of these 15 patients. All 15 patients were treated on a long-term basis with verapamil. The eight patients in whom epinephrine did not facilitate the induction of PSVT had no recurrences of PSVT during 9-18 months of follow-up.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Morady et al. (1989) studied paroxysmal supraventricular tachycardia (n=17). Epinephrine vs. Verapamil alone was evaluated on Induction of sustained paroxysmal supraventricular tachycardia. Epinephrine infusion reversed verapamil's electrophysiologic effects and facilitated PSVT induction in 46.7% (7 of 15) of patients whose arrhythmias were initially suppressed by verapamil.
Synapse has enriched 10 related papers. Consider them for comparative context: